Disease-modifying approach to the treatment of Alzheimer's disease: From α-Secretase activators to γ-secretase inhibitors and modulators

F Panza, V Solfrizzi, V Frisardi, C Capurso, A D'Introno… - Drugs & aging, 2009 - Springer
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …
被引用次数：121 相关文章

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators

F Panza, V Solfrizzi, V Frisardi, C Capurso… - Drugs & …, 2009 - pubmed.ncbi.nlm.nih.gov
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-Modifying Approach to the Treatment of Alzheimer's Disease

F Panza, V Solfrizzi, V Frisardi, C Capurso… - Drugs & …, 2009 - search.proquest.com
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

F Panza, V Solfrizzi, V Frisardi, C Capurso… - DRUGS & …, 2009 - fair.unifg.it
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-modifying approach to the treatment of Alzheimer's disease: from [alpha]-secretase activators to [gamma]-secretase inhibitors and modulators

F Panza, V Solfrizzi, V Frisardi, C Capurso, A D'Introno… - Drugs & Aging, 2009 - go.gale.com
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …
[PDF] academia.edu

[PDF][PDF] Disease-Modifying Approach to the Treatment of Alzheimer's Disease

F Panza, V Solfrizzi, V Frisardi, C Capurso, A D'Introno… - Drugs, 2009 - academia.edu
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

F Panza, V Solfrizzi, V Frisardi, C Capurso… - Drugs & …, 2009 - europepmc.org
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators.

F Panza, V Solfrizzi, V Frisardi, C Capurso… - Drugs & …, 2009 - search.ebscohost.com
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

Disease-modifying approach to the treatment of Alzheimer's disease from α-secretase activators to γ-secretase inhibitors and modulators.

F Panza, V Solfrizzi, V Frisardi, C Capurso… - Drugs & …, 2009 - psycnet.apa.org
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD)
have translated into an increase in clinical trials assessing various potential AD treatments …

[引用][C] Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators

F Panza, V Solfrizzi, V Frisardi, C Capurso… - DRUGS & …, 2009 - ricerca.uniba.it
Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase
activators to gamma-secretase inhibitors and modulators IRIS IRIS Home Sfoglia Macrotipologie …